Cargando…

K(ATP) Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation

Pharmacological modulation of ATP-sensitive potassium channels has become a promising new therapeutic approach for the treatment of neurodegenerative diseases due to their role in mitochondrial and cellular protection. For instance, diazoxide, a well-known ATP-sensitive potassium channel activator w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virgili, Noemí, Mancera, Pilar, Wappenhans, Blanca, Sorrosal, Georgina, Biber, Knut, Pugliese, Marco, Espinosa-Parrilla, Juan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770693/ https://www.ncbi.nlm.nih.gov/pubmed/24040400 http://dx.doi.org/10.1371/journal.pone.0075189

Ejemplares similares

Correction: K(ATP) Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation
por: Virgili, Noemí, et al.
Publicado: (2013)

Oral administration of the K(ATP )channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
por: Virgili, Noemí, et al.
Publicado: (2011)

Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice
por: Mancera, Pilar, et al.
Publicado: (2017)

Molecular determinants of ATP-sensitive potassium channel MgATPase activity: diabetes risk variants and diazoxide sensitivity
por: Fatehi, Mohammad, et al.
Publicado: (2015)

ATP-sensitive potassium (K(ATP)) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway
por: Roy Chowdhury, Uttio, et al.
Publicado: (2017)

Regulation of K(ATP) Channel Activity by Diazoxide and MgADP : Distinct Functions of the Two Nucleotide Binding Folds of the Sulfonylurea Receptor
por: Shyng, S.-L., et al.
Publicado: (1997)

Isosteviol Sensitizes sarcK(ATP) Channels towards Pinacidil and Potentiates Mitochondrial Uncoupling of Diazoxide in Guinea Pig Ventricular Myocytes
por: Fan, Zhuo, et al.
Publicado: (2016)

ATP—Sensitive Potassium Channel Opener Diazoxide Reduces Myocardial Stunning in a Porcine Regional With Subsequent Global Ischemia Model
por: Velez, Ana K., et al.
Publicado: (2022)

Diazoxide Attenuates Postresuscitation Brain Injury in a Rat Model of Asphyxial Cardiac Arrest by Opening Mitochondrial ATP-Sensitive Potassium Channels
por: Wu, Haidong, et al.
Publicado: (2016)

The mitochondrial K-ATP channel opener diazoxide upregulates STIM1 and Orai1 via ROS and the MAPK pathway in adult rat cardiomyocytes
por: Gavali, Joice T., et al.
Publicado: (2020)

Adenosine Triphosphate-Sensitive Potassium Channel Kir Subunits Implicated in Cardioprotection by Diazoxide
por: Henn, Matthew C, et al.
Publicado: (2015)

Diazoxide affects mitochondrial bioenergetics by the opening of mKATP channel on submicromolar scale
por: Akopova, Olga, et al.
Publicado: (2020)

Effects of diazoxide in experimental acute necrotizing pancreatitis
por: de Oliveira Andrade, Roberta, et al.
Publicado: (2017)

Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions
por: Friciu, Mihaela, et al.
Publicado: (2016)

The danger of diazoxide in the neonatal intensive care unit
por: Desai, Jay, et al.
Publicado: (2021)

Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension
por: Newman-Lindsay, Shoshana, et al.
Publicado: (2022)

Pharmacological Preconditioning Using Diazoxide Regulates Store-Operated Ca(2 +) Channels in Adult Rat Cardiomyocytes
por: Sampieri, Raúl, et al.
Publicado: (2020)

Diazoxide Promotes Oligodendrocyte Precursor Cell Proliferation and Myelination
por: Fogal, Birgit, et al.
Publicado: (2010)

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

Diazoxide preconditioning antagonizes cytotoxicity induced by epileptic seizures★
por: Fu, Qingxi, et al.
Publicado: (2013)

Prevalence and safety of diazoxide in the neonatal intensive care unit
por: Gray, Keyaria D, et al.
Publicado: (2018)

Diazoxide for Lowering Insulin Levels in Breast Cancer Patients
por: Fink, Michael K., et al.
Publicado: (2017)

Successful medical management of insulinoma with diazoxide for 27 years
por: Warren, Annabelle M, et al.
Publicado: (2020)

Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1
por: Sotiridou, Ellada, et al.
Publicado: (2021)

Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism
por: Boskabadi, Seyyed Javad, et al.
Publicado: (2023)

Pulmonary hypertension associated with diazoxide: the SUR1 paradox
por: Montani, David, et al.
Publicado: (2023)

Mitochondrial Channel Opener Diazoxide Attenuates Hypoxia-Induced sFlt-1 Release in Human Choriocarcinoma Cells
por: Shin, Byeong Seop, et al.
Publicado: (2014)

Kir1.1 and SUR1 are not implicated as subunits of an adenosine triphosphate-sensitive potassium channel involved in diazoxide cardioprotection
por: Wang, Jie, et al.
Publicado: (2023)

Anticonvulsant Effect of Diazoxide against Dichlorvos-Induced Seizures in Mice
por: Jazayeri, Amin, et al.
Publicado: (2013)

Diazoxide Maintains Human Myocyte Volume Homeostasis During Stress
por: Maffit, Sara K., et al.
Publicado: (2012)

A case of insulinoma effectively treated with low‐dose diazoxide
por: Yasuda, Atsushi, et al.
Publicado: (2020)

Necrotizing enterocolitis following diazoxide therapy for persistent neonatal hypoglycemia
por: Theodorou, Christina M., et al.
Publicado: (2019)

Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy
por: Sullivan, Rachel T., et al.
Publicado: (2021)

Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
por: Villoslada, Pablo, et al.
Publicado: (2015)

Cardiac Subsarcolemmal and Interfibrillar Mitochondria Display Distinct Responsiveness to Protection by Diazoxide
por: Holmuhamedov, Ekhson L., et al.
Publicado: (2012)

Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
por: Hussain, Suhaimi, et al.
Publicado: (2015)

Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia
por: Loke, Kah-Yin, et al.
Publicado: (2016)

Pulmonary hypertension occurring with diazoxide use in a preterm infant with hypoglycemia
por: Kylat, Ranjit I
Publicado: (2019)

Diazoxide for the Treatment of Hypoglycemia Resulting From Dumping Syndrome in a Child
por: Mejia-Otero, Juan D, et al.
Publicado: (2019)

Efficacy and safety of octreotide treatment for diazoxide‐unresponsive congenital hyperinsulinism in China
por: Cao, Bingyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gjl95i7jse83a7l3e7c0hhq55s